Dermatology Research Institute Inc. /ID# 210942

Calgary, Alberta T2J 7E1

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis — Completed